“The better-than-expected [first-quarter] performance was broad-based across the portfolio, with particular strength in life sciences and diagnostics,” Danaher said in a statement.
During Tuesday's TheStreet Live with Jim Cramer, he explains why he likes Danaher and tells investors when to buy.
Watch Everything Jim Cramer Is Watching Tuesday.
Curious about what Jim Cramer and his team at Action Alerts PLUS are watching in the markets? Watch Cramer's exclusive members-only Daily Rundown show on Action Alerts PLUS following TheStreet Live.